A detailed history of Morgan Stanley transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Morgan Stanley holds 84,939 shares of VRCA stock, worth $675,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,939
Previous 134,216 36.71%
Holding current value
$675,265
Previous $794,000 22.04%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
$5.89 - $9.56 $290,241 - $471,088
-49,277 Reduced 36.71%
84,939 $619,000
Q2 2024

Aug 14, 2024

SELL
$5.89 - $9.56 $290,241 - $471,088
-49,277 Reduced 36.71%
84,939 $619,000
Q1 2024

Oct 17, 2024

BUY
$4.74 - $6.81 $233,572 - $335,576
49,277 Added 58.01%
134,216 $794,000
Q1 2024

Aug 16, 2024

BUY
$4.74 - $6.81 $108,598 - $156,023
22,911 Added 20.58%
134,216 $794,000
Q1 2024

May 15, 2024

BUY
$4.74 - $6.81 $108,598 - $156,023
22,911 Added 20.58%
134,216 $794,000
Q4 2023

Aug 16, 2024

BUY
$2.93 - $7.32 $77,252 - $192,999
26,366 Added 31.04%
111,305 $814,000
Q4 2023

Feb 13, 2024

SELL
$2.93 - $7.32 $22,490 - $56,188
-7,676 Reduced 6.45%
111,305 $814,000
Q3 2023

Nov 15, 2023

BUY
$3.75 - $7.46 $267,397 - $531,942
71,306 Added 149.57%
118,981 $461,000
Q2 2023

Aug 14, 2023

SELL
$5.32 - $6.79 $620,939 - $792,515
-116,718 Reduced 71.0%
47,675 $275,000
Q1 2023

May 15, 2023

BUY
$2.88 - $8.51 $435,271 - $1.29 Million
151,136 Added 1140.05%
164,393 $1.07 Million
Q4 2022

Feb 14, 2023

SELL
$2.09 - $3.39 $60,831 - $98,669
-29,106 Reduced 68.71%
13,257 $36,000
Q3 2022

Nov 14, 2022

SELL
$2.17 - $4.3 $112,245 - $222,421
-51,726 Reduced 54.98%
42,363 $123,000
Q2 2022

Oct 27, 2022

SELL
$1.81 - $8.93 $1.24 Million - $6.14 Million
-687,623 Reduced 87.96%
94,089 $181,000
Q2 2022

Aug 15, 2022

SELL
$1.81 - $8.93 $1.24 Million - $6.14 Million
-687,623 Reduced 87.96%
94,089 $181,000
Q1 2022

Oct 27, 2022

BUY
$7.59 - $9.49 $5.22 Million - $6.53 Million
687,623 Added 730.82%
781,712 $6.34 Million
Q1 2022

May 13, 2022

SELL
$7.59 - $9.49 $981,204 - $1.23 Million
-129,276 Reduced 14.19%
781,712 $6.34 Million
Q4 2021

Feb 14, 2022

BUY
$9.1 - $13.36 $7.88 Million - $11.6 Million
866,408 Added 1943.49%
910,988 $8.35 Million
Q3 2021

Nov 15, 2021

BUY
$9.55 - $13.96 $425,739 - $622,336
44,580 New
44,580 $556,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.